Hariri Benjamin M, McMahon Derek B, Chen Bei, Adappa Nithin D, Palmer James N, Kennedy David W, Lee Robert J
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
PLoS One. 2017 Sep 20;12(9):e0185203. doi: 10.1371/journal.pone.0185203. eCollection 2017.
Flavones are a class of natural plant secondary metabolites that have anti-inflammatory and anti-bacterial effects. Some flavones also activate the T2R14 bitter taste receptor, which is expressed in motile cilia of the sinonasal epithelium and activates innate immune nitric oxide (NO) production. Flavones may thus be potential therapeutics for respiratory infections. Our objective was to examine the anti-microbial effects of flavones on the common sinonasal pathogens Candida albicans, Staphylococcus aureus, and Pseudomonas aeruginosa, evaluating both planktonic and biofilm growth. Flavones had only very low-level antibacterial activity alone. They did not reduce biofilm formation, but did reduce production of the important P. aeruginosa inflammatory mediator and ciliotoxin pyocyanin. However, flavones exhibited synergy against P. aeruginosa in the presence of antibiotics or recombinant human lysozyme. They also enhanced the efficacy of antimicrobials secreted by cultured and primary human airway cells grown at air-liquid interface. This suggests that flavones may have anti-gram-negative potential as topical therapeutics when combined with antibiotics or in the context of innate antimicrobials secreted by the respiratory or other epithelia. This may have an additive effect when combined with T2R14-activated NO production. Additional studies are necessary to understand which flavone compounds or mixtures are the most efficacious.
黄酮类化合物是一类具有抗炎和抗菌作用的天然植物次生代谢产物。一些黄酮类化合物还能激活T2R14苦味受体,该受体在鼻窦上皮的运动纤毛中表达,并激活先天性免疫一氧化氮(NO)的产生。因此,黄酮类化合物可能是治疗呼吸道感染的潜在药物。我们的目的是研究黄酮类化合物对常见的鼻窦病原体白色念珠菌、金黄色葡萄球菌和铜绿假单胞菌的抗菌作用,评估浮游菌和生物膜的生长情况。黄酮类化合物单独使用时仅具有极低水平的抗菌活性。它们不会减少生物膜的形成,但会减少铜绿假单胞菌重要的炎症介质和纤毛毒素绿脓菌素的产生。然而,在存在抗生素或重组人溶菌酶的情况下,黄酮类化合物对铜绿假单胞菌表现出协同作用。它们还增强了在气液界面培养的原代人气道细胞分泌的抗菌剂的功效。这表明,当与抗生素联合使用或在呼吸道或其他上皮细胞分泌的先天性抗菌剂的背景下,黄酮类化合物作为局部治疗药物可能具有抗革兰氏阴性菌的潜力。当与T2R14激活的NO产生联合使用时,这可能会产生累加效应。有必要进行更多研究以了解哪些黄酮类化合物或混合物最有效。